Patient profiles and outcomes of chronic total occlusion percutaneous revascularisation in middle- and high-income regions a cross-sectional study from the European Registry of Chronic Total Occlusions (ERCTO).
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vadalà Giuseppe, Mashayekhi Kambis, Madaudo Cristina, Behnes Michael, Ayoub Mohamed, Gorgulu Sevket, Werner Gerald S, Kalay Nihat, Avran Alexander, Goktekin Omer, Garbo Roberto, Jaroslaw Wojcik, Zaczkiewicz Myron, Arnez Juergen, Pyxaras Stylianos, Christiansen Evald Høj, Gutiérrez-Chico Juan Luis, Boudou Nicolaus, Stojkovic Sinisa, Gasparini Gabriele L, Agostoni Pierfrancesco, Diletti Roberto, di Mario Carlo, Maniscalco Laura, Bulum Josko, Cenko Edina, Galassi Alfredo R, EURO CTO investigators
Аннотация
OBJECTIVE: To compare the clinical profiles, procedural settings and outcomes of patients undergoing CTO-PCI in middle-income countries (MICs) and high-income countries (HICs).
METHODS: This cross-sectional study included 15,329 patients who underwent CTO-PCI between 2021 and 2023. Data were obtained from the European Registry of Chronic Total Occlusions (ERCTO). Of the 24 enrolling countries, 7 were classified as MICs and 14 as HICs.
RESULTS: Patients in HICs were older (67 ± 10 vs 61 ± 10 years; p < 0.001) and presented with greater CTO complexity (J-CTO score: 2.31 ± 1.25 vs 1.99 ± 1.17; p < 0.001). Conversely, patients in MICs were more likely to have diabetes (35% vs 29%; p < 0.001) and to be active smokers (59% vs 49%; p < 0.001). Patients in MICs had lower use of mechanical cardiac support (0.1% vs 0.8%; p < 0.001), advanced calcific plaque modification devices (1% vs 6.1%; p < 0.001), and intravascular ultrasound (14% vs 25%; p < 0.001). MICs achieved higher procedural success (89.5% vs 90.5%; p = 0.07) but higher mortality compared to HICs (0.6% vs 0.2%; p < 0.001).
CONCLUSION: Among a selected population of patients undergoing CTO-PCI, notable clinical, anatomical, and procedural differences exist between MICs and HICs. These findings highlight the importance of tailoring public health strategies to optimise cardiovascular care across diverse economic settings.